Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Artara Therapeutics Inc (TARA)

Artara Therapeutics Inc (TARA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Artara Therapeutics Inc 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 USA

P: 646-844-0337

Description:

Protara Therapeutics Inc. is committed to identifying and advancing transformative therapies for rare and specialty diseases. The company's portfolio includes, TARA-002, an investigational cell therapy being developed for the treatment of lymphatic malformations, and intravenous Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. Protara Therapeutics Inc., formerly known as ArTara Therapeutics, is based in NEW YORK, United States.

Key Statistics

Overview:

Market Capitalization, $K 75,843
Shares Outstanding, K 11,236
Annual Sales, $ 0 K
Annual Net Income, $ -33,980 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,780 K
60-Month Beta 0.79
% of Insider Shareholders 11.30%
% of Institutional Shareholders 63.33%
Float, K 9,966
% Float 88.70%

Growth:

1-Year Return -70.10%
3-Year Return -90.67%
5-Year Return -91.82%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 90.96%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/11/21
Earnings Per Share ttm -4.09
EPS Growth vs. Prev Qtr 15.79%
EPS Growth vs. Prev Year 23.81%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-40 on 01/10/20

TARA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -24.90%
Return-on-Assets % -23.96%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.42
Book Value/Share 15.16
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar